Simulations Plus develops pharmaceutical simulation software that helps scientists to develop new drugs from chemical's biological structures. Read more
Simulations Plus's Competitors, Revenue, Number of Employees, Funding and Acquisitions
56 Followers on Owler
CEO
Shawn O’Connor
Annual Revenue
Employees
Sector
Headquarters
TOP COMPETITORS OR ALTERNATIVES
Missing a competitor? Contribute!
Certara is one of Simulations Plus's top competitors. Certara is a Private company that was founded in Princeton, New Jersey in 2008. Certara is in the Health Care Services field. Certara has 743 more employees vs. Simulations Plus.
Weigh-in!
Help the Owler community know moreExplore companies in similar locations and sectors
Trending News for Simulations Plus and Simulations Plus's Competitors
August 4, 2020
BioSpace
Simulations Plus Announces Proposed Underwritten Public Offering - Aug 04, 2020
Simulations Plus, Inc., a premier developer of drug discovery and development software for modeling a... See more »
August 3, 2020
Picante Today
Schrdinger to Host Second Quarter 2020 Financial Results Conference Call and Webcast
NEW YORK-(BUSINESS WIRE)-Schrödinger (Nasdaq: SDGR), whose physics-based software platform enables di... See more »
August 4, 2020
Zacks
Pacific Biosciences (PACB) Posts Lower-Than-Expected Q2 Loss
Pacific Biosciences (PACB) saw revenue decline in both its operating segments in Q2.... See more »
Quarterly and Annual Revenue
Trailing 12-Months Trend (TTM)
Annual Revenue
$40.1M
Simulations Plus's revenue is the ranked 3rd among it's top 10 competitors. The top 10 competitors average 38.9M. Over the last four quarters, Simulations Plus's revenue has grown by 53.2%. Specifically, in Q2 2020's revenue was $12.3M; in Q1 2020, it was $10.3M; in Q4 2019, it was $9.4M; in Q3 2019, Simulations Plus's revenue was $8M.
Acquisitions
COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Lixoft SAS
Apr 2020
Source »$11M
Lixoft develops a pharmaceutical simulation software that provides drug design and molecular modeling solutions for the biotechnology sector.
DILIsym Services, Inc.
May 2017
Source »undisclosed
DILIsym is a provider of drug-induced liver injury-simulation software and related consulting services to the pharmaceutical industry.
Cognigen Corporation
Jul 2014
Source »$7M
Cognigen provides strategic pharmacology and pharmacometric consulting services.
These are all the companies that Simulations Plus has acquired. Simulations Plus has acquired 5 companies and its latest acquisition was Lixoft SAS in Apr 2020. Lixoft develops a pharmaceutical simulation software that provides drug design and molecular modeling solutions for the biotechnology sector.
Simulations Plus Funding History
Since Simulations Plus was founded in 1996, it has participated in 1 round of funding. In total Simulations Plus has raised $5.8M. Simulations Plus' funding round was on Jun 1997 for a total of $5.8M
ROUND
FUNDING DATE
AMOUNT
INVESTORS
IPO
Jun 1997
$5.8M
Total Funding: $5.8M
Since Simulations Plus was founded in 1996, it has participated in 1 round of funding. In total Simulations Plus has raised $5.8M. Simulations Plus' funding round was on Jun 1997 for a total of $5.8M
Investments
No recent investments found related to Simulations Plus
Simulations Plus News
July 9, 2020Drug Genius
Simulations Plus Reports Third Quarter FY2020 Financial Results
Third Quarter and 9MoFY20 Revenues Grow 24% Board of Directors Announces Quarterly Dividend of $0.06 ... See more »
July 2, 2020BioSpace
Simulations Plus Sets Date for 3rd Quarter 2020 Earnings Release and Conference Call
Simulations Plus, Inc. (Nasdaq: SLP) announced today that it expects to file its quarterly report on ... See more »
May 28, 2020MarketScreener
Receives New Grant Award from the FDA
(marketscreener.com) Novel PBPK/PD modeling strategies for ophthalmic drug products will inform regul... See more »
May 6, 2020Associated Press News
U.S. FDA Renews Annual DILIsym Software Licenses
Press release content from Business Wire. The AP news staff was not involved in its creation.... See more »
April 18, 2020DirectorsTalk Interviews
Simulations Plus - Consenus Indicates Potential 5.6% Upside
Simulations Plus with ticker code (SLP) have now 2 analysts covering the stock. The analyst consensus... See more »
Simulations Plus Press Releases
January 9, 2019StreetInsider
Simulations Plus Reports First Quarter FY2019 Financial Results
Simulations Plus, Inc. (Nasdaq: SLP), the leading provider of modeling and simulation solutions for t... See more »
January 24, 2018MarketersMedia
Simulations Plus Has a Dividend Yield of 1.47%; Will Trade Ex-Dividend on January 25, 2018
LONDON, UK / ACCESSWIRE / January 24, 2018 / Active-Investors has a free review on Simulations Plus, ... See more »
July 18, 2017streetinsider
Simulations Plus Announces Quarterly Cash Dividend of $0.05 per Share
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and cons... See more »
July 9, 2017StreetInsider
Simulations Plus Reports Third Quarter FY2017 Financial Results
Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and co... See more »
July 4, 2017StreetInsider
Simulations Plus Sets Date for 3rd Quarter 2017 Earnings Release and Conference Call
Simulations Plus, Inc. (Nasdaq: SLP) announced today that it expects to file its quarterly report on ... See more »
August 1, 2016Business Wire
Simulations Plus Releases ADMET Predictor Version 8.0
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced the release of ADMET Predictor 8... See more »
July 13, 2016Business Wire
Simulations Plus Reports Third Quarter FY2016 Financial Results
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today reported record results for the 3rd quarte... See more »
Simulations Plus Videos
June 23, 2020Simulations Plus Youtube Channel
"The GastroPlus Additional Dosage Routes Seminar Series Transdermal with Jessica Spires" on YOUTUBE
June 23, 2020Simulations Plus Youtube Channel
"GastroPlus "Workshop from Home" April 17 PBPK PD modeling course with Haiying Zhou" on YOUTUBE
May 7, 2020Simulations Plus Youtube Channel
"Deployment of ADMET Predictor as a Solution for In-Silico Modeling of ADMET Properties" on YOUTUBE
April 10, 2020Simulations Plus Youtube Channel
"Simulations Plus Second Quarter Fiscal Year 2020 Financial Results" on YOUTUBE
April 10, 2020Simulations Plus Youtube Channel
"Early assessment of PK properties with the ADMET Predictor HTPK Simulation module" on YOUTUBE
April 9, 2020Simulations Plus Youtube Channel
"Live Stream Learning with Simulations Plus - Day Two" on YOUTUBE
April 3, 2020Simulations Plus Youtube Channel
"Clinical DILI and State of the Art Solutions" on YOUTUBE
Social Statistics
Headquarters
Trending Companies
IN THE NEWS
AbbVie | Cycling UK | Marcus | Norwegian Cruise Line | GW Plastics | FTI Consulting | Geli | FortNine | ABC Supply | Peloton | NVIDIA | OnePlus | Banco do Brasil | NKF | Aptitude Habilitation Services, Inc.. Proudly created with Wix.com | Gold Rush Cariboo | Salesforce | SALMON EVOLUTION | DBS Bank | Emirates | AstraZeneca | Fractyl | Zibo | Hall of Fame Resort | Sanzo | Moderna | Bristol Myers Squibb | BASF | Lockheed Martin | Mylan | Enlabeler | Netflix | Aviva | Lepu | Oak Street Health | Obsidio | Western Union | Mitsuichem | YCI | Zoetis | NICE Systems | Credit Agricole | Tata Motors | Flotek | Agenus | O-I | Manchester United | BRIO | Sealed Air | Enstructure LLC
PEOPLE ALSO VIEWED
Dotworkz Systems | Factory Authorized | Pass Auto Glass | Superveillance Creative Video | Comunidad Baterias Ecuador | Tec Way | Psytech | Artful Soul | Supermarche Leclerc | Tembatoo Granola | Radiant Info Solutions | Classcraft Studios | Fmylife | Tires By Design | 3AxisData | Demes | Mar Vista | Playdoit | United Academy South - Wildomar | Mnet | The Evil Weevil - Tying Flies With Jeremy | Nikki, In Stitches Crafty Academy | Darlington Learning Zone | Remassociatesltd | Multiple Marketing | Y.shop | Paddlewheel Popcorn | Su Carburetors | Aavanam | Ellis Suites
Summary
ABOUT
Overview
Simulations Plus develops pharmaceutical simulation software that helps scientists to develop new drugs from chemical's biological structures. Simulations Plus was founded in 1996. Simulations Plus' headquarters is located in Lancaster, California, US...
CEO
Simulations Plus's CEO, Shawn O’Connor, currently has an approval rating of 84%. Simulations Plus's primary competitors are Certara, Schrodinger & AnyLogic.Website
simulations-plus.comFrequently Asked Questions about Simulations Plus
When was Simulations Plus founded?
Simulations Plus was founded in 1996Who is Simulations Plus's CEO?
Simulations Plus's CEO is Shawn O’ConnorHow much revenue does Simulations Plus generate?
Simulations Plus generates $40.1M in revenueHow much funding does Simulations Plus have?
Simulations Plus has historically raised $5.8M in funding
Where is Simulations Plus's headquarters?
Simulations Plus's headquarters is in Lancaster California, USAHow many employees does Simulations Plus have?
Simulations Plus has 107 employeesWhat sector does Simulations Plus operate in?
Simulations Plus is in Health Care ServicesWho are Simulations Plus's competitors?
Simulations Plus's top competitors are Certara, Schrodinger, AnyLogic
